Stock ScreenerStock IdeasStock ForecastsStock Predictions & Stock Market Forecast 2025, 2026, 2027, 2028, 2029View analyst forecasts, price targets, buy/sell ratings, revenue/earnings forecasts and more
Stock ScreenerStock IdeasStock Forecasts
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAFAU | LAFAYETTE ACQUISITION CORP | N/A | N/A | N/A | N/A | N/A | -5.79 | N/A | N/A | N/A | N/A | ||
| EFTY | ETOILES CAPITAL GROUP CO LTD | N/A | N/A | N/A | 112.09% | N/A | 1.33 | 1.50 | 78.80% | 33.80% | 39.62% | ||
| KLAR | KLARNA GROUP PLC | N/A | N/A | N/A | N/A | N/A | 7.13 | N/A | N/A | N/A | N/A | ||
| DKI | DARKIRIS INC | N/A | N/A | N/A | N/A | N/A | 0.48 | 3.03 | N/A | N/A | N/A | ||
| STKE | SOL STRATEGIES INC | N/A | N/A | N/A | N/A | N/A | 0.61 | N/A | N/A | N/A | N/A | ||
| CHECU | CHENGHE ACQUISITION III CO | N/A | N/A | N/A | 149.17% | N/A | -16.67 | N/A | N/A | N/A | N/A | ||
| YCY.U | AA MISSION ACQUISITION CORP II | N/A | N/A | N/A | N/A | N/A | -18.87 | 0.17 | N/A | N/A | N/A | ||
| DMIIU | DRUGS MADE IN AMERICA ACQUISITION II CORP | N/A | N/A | N/A | N/A | N/A | -1.53 | 0.04 | N/A | N/A | N/A | ||
| LKSPU | LAKE SUPERIOR ACQUISITION CORP | N/A | N/A | N/A | N/A | N/A | -2.39 | N/A | N/A | N/A | N/A | ||
| DLXY | DELIXY HOLDINGS LTD | N/A | 64.70% | 6.00% | 17.67% | 130.60% | 16.49 | 1.29 | 1.40% | 0.30% | 0.36% | ||
| LBRX | LB PHARMACEUTICALS INC | N/A | N/A | N/A | N/A | N/A | -0.09 | 3.78 | N/A | N/A | N/A | ||
| EMPG | EMPRO GROUP INC | N/A | 69.70% | 19.70% | 54.59% | 42.70% | 4.10 | 1.45 | 61.80% | 13.70% | 20.11% | ||
| CEPF | CANTOR EQUITY PARTNERS IV INC | N/A | N/A | N/A | N/A | N/A | -3.51 | N/A | N/A | N/A | N/A | ||
| NSRX | NASUS PHARMA LTD | N/A | N/A | N/A | 46.79% | N/A | -1.22 | 0.12 | N/A | N/A | N/A | ||
| AEXA | AMERICAN EXCEPTIONALISM ACQUISITION CORP A | N/A | N/A | N/A | N/A | N/A | 6.16 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.